Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of cizolirtine versus placebo and tolterodine for urge urinary incontinence
2004-001116-31Phase 3Completed
- Sponsor
- Esteve
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cizolirtine in urge incontinence (4 arms), sponsored by Esteve. Primary endpoint: Primary efficacy variable. Started Oct 2004; status: completed.
02
Drugs
cizolirtine
03
Conditions
urge incontinence
Beyond the preview
Go deeper on 2004-001116-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001116-31.